Cargando…
Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance
AIM: To compare accuracy, efficacy and acceptance of implantable and transcutaneous continuous glucose monitoring (CGM) systems. METHODS: In a randomized crossover trial we compared 12 weeks with Eversense implantable sensor (EVS) and 12 weeks with Dexcom G5 transcutaneous sensor (DG5) in terms of a...
Autores principales: | Boscari, F., Vettoretti, M., Cavallin, F., Amato, A. M. L., Uliana, A., Vallone, V., Avogaro, A., Facchinetti, A., Bruttomesso, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246426/ https://www.ncbi.nlm.nih.gov/pubmed/34196924 http://dx.doi.org/10.1007/s40618-021-01624-2 |
Ejemplares similares
-
Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care
por: Boscari, Federico, et al.
Publicado: (2022) -
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown
por: Boscari, Federico, et al.
Publicado: (2021) -
Real-Time Improvement of Continuous Glucose Monitoring Accuracy: The smart sensor concept
por: Facchinetti, Andrea, et al.
Publicado: (2013) -
Glycemic control after switching to faster aspart in adults with type 1 diabetes
por: Fadini, G. P., et al.
Publicado: (2022) -
Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review
por: Vettoretti, Martina, et al.
Publicado: (2019)